Evaluation of cobalt nanoparticles suspension as antifungal agent in treatment of cutaneous candidiasis

Over the last ten years, nanomaterials have been extensively employed in the medical field and several essential industries. It is used mainly in developing novel antimicrobials as an alternative to conventional agents. This research emphasizes synthesizing cobalt nanoparticles (CoNPs) and testing t...

Full description

Saved in:
Bibliographic Details
Main Authors: Hassan Ayad Kareem, Hayder Mahmood Samaka, Wasna'a Mohamed Abdulridha
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Kuwait Journal of Science
Subjects:
Online Access:https://www.sciencedirect.com/science/article/pii/S2307410823000044
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850243366479986688
author Hassan Ayad Kareem
Hayder Mahmood Samaka
Wasna'a Mohamed Abdulridha
author_facet Hassan Ayad Kareem
Hayder Mahmood Samaka
Wasna'a Mohamed Abdulridha
author_sort Hassan Ayad Kareem
collection DOAJ
description Over the last ten years, nanomaterials have been extensively employed in the medical field and several essential industries. It is used mainly in developing novel antimicrobials as an alternative to conventional agents. This research emphasizes synthesizing cobalt nanoparticles (CoNPs) and testing their antifungal activity in treating cutaneous candidiasis. Cobalt nanoparticles (CoNPs) were synthesized from Cobalt Sulfate heptahydrate (CoSO4·7H2O) using hydrazine monohydrate as a reducing agent. The CoNPs suspension was analyzed using X-ray diffraction, atomic force microscopy (AFM), and the field emission scanning electron microscope to determine the crystallographic and morphological properties and concentration of the produced CoNPs. The antifungal activity of the CoNPs suspension was confirmed in-vitro by the agar well diffusion method and in-vivo by treating an induced case of cutaneous candidiasis in Sprague Dawley rats as a model. The experimental results demonstrated that CoNPs suspension exhibited antifungal action in-vitro (on the plates) and that Candida albicans required a concentration of 9.4 ​μg/mL as the minimum inhibitory concentration. In contrast, data shows that the plate's inhibition zone improved due to increased CoNPs concentration in the prepared suspension. The in-vivo experiment shows complete healing of the skin lesion on day six for the rats' group treated with CoPNs suspension, and on day five in the rats' group treated with Nystatin. These results demonstrate that CoPNs suspension is effective in treating cutaneous candidiasis in Sprague Dawley rats; however, it is still less effective than Nystatin.
format Article
id doaj-art-b1461dcb1ecc4a5cb4b15bff6b554d15
institution OA Journals
issn 2307-4108
2307-4116
language English
publishDate 2023-04-01
publisher Elsevier
record_format Article
series Kuwait Journal of Science
spelling doaj-art-b1461dcb1ecc4a5cb4b15bff6b554d152025-08-20T02:00:02ZengElsevierKuwait Journal of Science2307-41082307-41162023-04-015022225https://doi.org/10.1016/j.kjs.2023.02.004Evaluation of cobalt nanoparticles suspension as antifungal agent in treatment of cutaneous candidiasisHassan Ayad Kareem0Hayder Mahmood Samaka1Wasna'a Mohamed Abdulridha2Department of Microbiology, Al-Toosi University College, Al-Najaf, IraqDepartment of Vet. Microbiology, Faculty of Veterinary Medicine, University of Kufa, Al-Najaf, IraqDepartment of Basic Sciences, College of Dentistry, University of Kufa, Al-Najaf, IraqOver the last ten years, nanomaterials have been extensively employed in the medical field and several essential industries. It is used mainly in developing novel antimicrobials as an alternative to conventional agents. This research emphasizes synthesizing cobalt nanoparticles (CoNPs) and testing their antifungal activity in treating cutaneous candidiasis. Cobalt nanoparticles (CoNPs) were synthesized from Cobalt Sulfate heptahydrate (CoSO4·7H2O) using hydrazine monohydrate as a reducing agent. The CoNPs suspension was analyzed using X-ray diffraction, atomic force microscopy (AFM), and the field emission scanning electron microscope to determine the crystallographic and morphological properties and concentration of the produced CoNPs. The antifungal activity of the CoNPs suspension was confirmed in-vitro by the agar well diffusion method and in-vivo by treating an induced case of cutaneous candidiasis in Sprague Dawley rats as a model. The experimental results demonstrated that CoNPs suspension exhibited antifungal action in-vitro (on the plates) and that Candida albicans required a concentration of 9.4 ​μg/mL as the minimum inhibitory concentration. In contrast, data shows that the plate's inhibition zone improved due to increased CoNPs concentration in the prepared suspension. The in-vivo experiment shows complete healing of the skin lesion on day six for the rats' group treated with CoPNs suspension, and on day five in the rats' group treated with Nystatin. These results demonstrate that CoPNs suspension is effective in treating cutaneous candidiasis in Sprague Dawley rats; however, it is still less effective than Nystatin.https://www.sciencedirect.com/science/article/pii/S2307410823000044candida albicanscobalt nanoparticlescutaneous candidiasisfungal skin infectioncobalt sulfate heptahydrate
spellingShingle Hassan Ayad Kareem
Hayder Mahmood Samaka
Wasna'a Mohamed Abdulridha
Evaluation of cobalt nanoparticles suspension as antifungal agent in treatment of cutaneous candidiasis
Kuwait Journal of Science
candida albicans
cobalt nanoparticles
cutaneous candidiasis
fungal skin infection
cobalt sulfate heptahydrate
title Evaluation of cobalt nanoparticles suspension as antifungal agent in treatment of cutaneous candidiasis
title_full Evaluation of cobalt nanoparticles suspension as antifungal agent in treatment of cutaneous candidiasis
title_fullStr Evaluation of cobalt nanoparticles suspension as antifungal agent in treatment of cutaneous candidiasis
title_full_unstemmed Evaluation of cobalt nanoparticles suspension as antifungal agent in treatment of cutaneous candidiasis
title_short Evaluation of cobalt nanoparticles suspension as antifungal agent in treatment of cutaneous candidiasis
title_sort evaluation of cobalt nanoparticles suspension as antifungal agent in treatment of cutaneous candidiasis
topic candida albicans
cobalt nanoparticles
cutaneous candidiasis
fungal skin infection
cobalt sulfate heptahydrate
url https://www.sciencedirect.com/science/article/pii/S2307410823000044
work_keys_str_mv AT hassanayadkareem evaluationofcobaltnanoparticlessuspensionasantifungalagentintreatmentofcutaneouscandidiasis
AT haydermahmoodsamaka evaluationofcobaltnanoparticlessuspensionasantifungalagentintreatmentofcutaneouscandidiasis
AT wasnaamohamedabdulridha evaluationofcobaltnanoparticlessuspensionasantifungalagentintreatmentofcutaneouscandidiasis